Single cell genome sequencing allows researchers to study complex biological systems at a cellular level by sequencing genomes of individual cells. It helps reveal heterogeneity and rare cell populations in tissues and tumors. This provides invaluable insights into cell differentiation, gene expression variability, and immune cell functions which is crucial for understanding embryogenesis, cancer evolution and immunology.
Market key trends:
The adoption of single cell genome sequencing in biopharmaceutical research and drug discovery is one of the major trends boosting the market growth. Single cell analysis helps in developing personalized medicines by enabling researchers to identify biomarkers, drug resistance mechanisms and rare cell populations. It is being extensively used to develop cell and gene therapies as well as cancer immunotherapy. Single cell genome sequencing provides detailed analysis of cell heterogeneity, mutations and interaction between different cell types which is helpful for developing targeted therapies. The rising funds for genomics research from government as well as private sources is also fueling the demand for single cell sequencing solutions.
Segment Analysis
The global single cell genome sequencing market is dominated by clinical applications segment. Clinical applications of single cell genome sequencing help in understanding diseases at single cell level. It aids in developing personalized treatment strategies by analysing genomic variations between healthy and diseased cells. Further, rising incidence of chronic diseases is driving growth of clinical applications segment.
Key Takeaways
Global Single Cell Genome Sequencing Market Size Growth Accelerated By Adoption Of Single Cell Genome Sequencing In Biopharma Research is expected to witness high growth over the forecast period of 2023 to 2030. The global Single Cell Genome Sequencing Market is estimated to be valued at US$ 2.28 Bn in 2023 and is expected to exhibit a CAGR of 3.9% over the forecast period 2023 to 2030.
Regional analysis: North America dominated the market in 2023 with a share of over 35%, due to presence of major players and extensive R&D activities in the region. Asia Pacific is expected to be the fastest growing region on account of rising government funding for genomics projects and increasing healthcare expenditure.
Key players: Key players operating in the single cell genome sequencing market are 10x Genomics, Fluidigm Corporation, Bio-Rad Laboratories, BGI, Illumina Inc., Pacific Biosciences of California, Novogene Corporation, Danaher, Qiagen and NanoString Technologies. 10x Genomics dominates the market owing to its robust product portfolio for single cell genome sequencing and analysis.
Explore More Related Article On This Topic: https://www.newsanalyticspro.com/the-single-cell-genome-sequencing-market-is-poised-for-remarkable-growth/
Explore More Related Article: https://themediumblog.com/training-market-is-estimated-to-witness-high-growth/
Comments
0 comment